Orris

Adult BCG vaccination.

Reading File
Finding Sources
Finding Sources
Searching PubMed

"BCG vaccine" AND adult

Searching the Web

adult BCG vaccination indications guidelines 2026

Reading File
Reading File

Adult BCG Vaccination

What it is BCG (Bacille Calmette-Guérin) is a live attenuated vaccine derived from Mycobacterium bovis that has lost its virulence for humans. It is given as a single intradermal dose, classically on the left upper arm - the left side is used simply to standardize documentation and surveillance, not for any biological reason (Park's Textbook of Preventive and Social Medicine).
Why adult BCG is different from infant BCG BCG's strongest and best-established benefit is protection against severe, disseminated forms of childhood TB - miliary TB and TB meningitis - which is why it is given routinely to infants in high-burden countries. In adults, the evidence is much weaker: BCG "is quite effective at protecting against serious disseminated tuberculosis in children but is not protective against adult pulmonary tuberculosis" (Janeway's Immunobiology, 10e). Goodman & Gilman's notes that overall vaccine efficacy against TB "is uncertain in many settings," though the consensus benefit against the most severe disease forms holds. It remains a WHO essential medicine for TB-endemic areas but is not part of universal adult immunization in low-incidence countries like the US.
Who should actually get it as an adult Based on current national guidance (NHS/UK, CDC framework, StatPearls):
  • Adults over 16 moving to or spending more than 3 months in a country with a high TB burden, particularly if living closely with local communities.
  • Healthcare workers (any age) who will have regular contact with TB patients or clinical specimens, especially in settings with multidrug-resistant TB exposure risk, and who are TST/IGRA-negative (no prior TB exposure).
  • It is generally not given to adults who already have a positive tuberculin skin test (TST) or interferon-gamma release assay (IGRA), since this indicates prior sensitization and raises the risk of a severe local reaction rather than added benefit.
Contraindications Because it is a live vaccine, BCG should not be given to:
  • Immunocompromised adults (HIV infection, chemotherapy, high-dose steroids, other significant immunosuppression)
  • Pregnant women
Adverse events The Red Book (Committee on Infectious Diseases) lists BCG-associated suppurative/regional lymphadenitis (a lymph node swelling wider than an adult finger width, or a draining sinus) as the main recognized complication, typically appearing 2-6 months after vaccination and almost exclusively linked to BCG among vaccines.
Newer/off-label uses under investigation Recent systematic reviews and meta-analyses have looked at BCG beyond TB prevention in adults:
  • COVID-19: a 2025 meta-analysis of RCTs (PMID: 40359420) examined BCG's non-specific ("trained immunity") protective effect against COVID-19 in health care workers and non-health care workers - results have been mixed and are not strong enough to support BCG as a COVID prevention strategy.
  • Type 1 diabetes: a 2024 systematic review/meta-analysis (PMID: 39173532) looked at repeated BCG vaccination as an immunotherapy to reduce HbA1c/insulin needs in T1D - an active research area, not a standard indication.
  • Updated pediatric BCG efficacy data (PMID: 40250749, 2025) and individual-participant-data meta-analysis on primary BCG effectiveness (PMID: 39709975, Lancet Microbe 2025) reaffirm efficacy is concentrated in children/infants, reinforcing that adult protection against pulmonary TB specifically remains unproven.
Bottom line: For most adults, BCG vaccination is not routine. It is reserved for specific risk groups - unvaccinated, TST/IGRA-negative healthcare workers with TB exposure risk, and long-stay travelers (>3 months) to high-TB-burden countries - and it should not be given to immunocompromised or pregnant adults. Repurposed uses (COVID-19, autoimmune disease) remain investigational and are not yet supported strongly enough to change clinical practice.
  • Janeway's Immunobiology, 10e
  • Goodman & Gilman's The Pharmacological Basis of Therapeutics
  • Park's Textbook of Preventive and Social Medicine
  • Red Book 2021, Report of the Committee on Infectious Diseases
This is a shared conversation. Sign in to Orris to start your own chat.